Case Study
Nucleic Acid Drug Design

Inquiry
Nucleic Acid Drug Design
Proto-enabled DNA & RNA design services

Design nucleic acids around function, not guesswork.

We translate biological objectives into multi-objective computational design campaigns—generating, optimizing, and ranking DNA and RNA candidates for focused experimental testing.

Regulatory DNARNA splicingUTR controlMulti-model scoringReproducible programs
cell-selective regulatory cassette / design campaign
Candidate architecture Optimized
Variable enhancer · 500 bp
Promoter · 100 bp
Intron · 301 bp
3′ UTR switch · 400 bp
ACGGTACCTGAGTCTAGGCT...GTAGCTAACGTTGACCTGAA...CCTGAGGTAAGTCCAG...
Target-cell regulatory signal↑ 3.8×
Off-target predicted activity↓ 71%
Define variables
Generate
Score & optimize
Rank candidates
DNASequence-to-function design
RNASplicing and post-transcriptional control
ΣMulti-objective optimization
Reproducible design programs
Service portfolio

Computational design services across the nucleic acid stack.

Each engagement is scoped around a biological objective, an explicit design space, a set of predictive constraints, and a practical experimental handoff.

01

Regulatory DNA design

Generate and optimize enhancers, promoters, transcription-factor response elements, and noncoding regulatory regions for target activity and reduced off-target signal.

ENHANCERSPROMOTERSTF MOTIFS
02

RNA splicing design

Design synthetic introns and splice-regulatory elements with target donor/acceptor usage, cell-context specificity, and explicit cryptic-splice risk analysis.

INTRONSSSUCRYPTIC SITES
03

UTR and RNA control

Optimize 5′/3′ UTR architecture, microRNA response elements, sequence composition, and post-transcriptional control logic for context-dependent expression.

3′ UTRmiRNARNA STABILITY
04

CRISPR and noncoding RNA systems

Build computational generation and filter cascades for guide, array, tracrRNA, and broader locus architectures, with sequence-quality and structural plausibility checks.

GUIDESARRAYSLOCUS FILTERING
05

Multi-layer regulatory cassettes

Coordinate enhancer, promoter, intron, and UTR design as a staged program so that several regulatory layers contribute complementary selectivity.

GENE CIRCUITSCELL SELECTIVITYSTAGED DESIGN
06

Custom Proto workflow engineering

Translate a research brief into a documented Proto program, select appropriate generators and constraints, run design sweeps, and deliver an auditable analysis package.

PROTO PROGRAMSMODEL INTEGRATIONREPRODUCIBILITY
Engagement workflow

From biological brief to an experiment-ready shortlist.

The program is designed around explicit trade-offs rather than a single prediction score. That makes the rationale, failure modes, and candidate selection criteria easier to inspect.

1

Scope the design objective

Define target and off-target contexts, mutable regions, fixed sequence context, success criteria, assay plan, and synthesis constraints.

2

Encode the design program

Map each sequence region to generators and constraints, select optimization stages, and establish positive, negative, and baseline controls.

3

Generate and optimize candidates

Run broad candidate generation followed by focused refinement using rejection sampling, MCMC, gradient-based search, or beam search where appropriate.

4

Stress-test the shortlist

Evaluate model agreement, sequence diversity, genomic or plasmid context robustness, motif liabilities, cryptic splice sites, and single-mutation sensitivity.

5

Deliver a decision package

Provide ranked sequences, per-constraint scorecards, design rationale, reproducible code or program files, and a recommended experimental panel.

Standard deliverables

Not just sequences—a traceable design decision.

Every candidate is accompanied by the context needed to decide what to synthesize, what to test, and what could fail.

Design package

Ranked candidate libraryFASTA/CSV with sequence IDs and metadata
Constraint score matrixPer-model and composite objective breakdown
Context robustness reportFlank, locus, cell-type, or construct sensitivity
Risk and liability checksMotifs, repeats, homopolymers, cryptic splice events
Candidate diversity mapClustering to avoid redundant experimental picks
Reproducible workflowProto program, configuration, and methods summary
Published platform evidence

Case studies that demonstrate the design pattern.

These examples are reported in the Proto preprint and are shown as evidence of platform capability—not as client results from this independent service concept.

32%of successfully assayed ProtoIntrons showed significant differential splicing in the intended direction.
Experimentally evaluated

Cell-line-specific synthetic introns

AlphaGenome and SpliceTransformer constraints were combined with MCMC optimization across multiple sequence contexts. Sixty-five candidates were screened, with hits recovered in three of four design directions.

Source: Merchant et al., 2026 preprint, Figure 3 and Results §2.3.
45 / 86designed σ70 promoters drove reporter expression more than tenfold above a no-promoter control.
Experimentally evaluated

Synthetic bacterial promoter design

Evo 2 generation, promoter-strength and motif constraints, rejection sampling, and MCMC refinement produced diverse promoters with preserved σ70 grammar. Seventy-one of 86 exceeded the activity of PLtetO1 in the reported assay.

Source: Merchant et al., 2026 preprint, Figure 4 and Results §2.4.
5 layersenhancer, promoter, intron, 3′ UTR off-switch, and an entry-bias component in one staged program.
Computational proof-of-concept

Cell-selective regulatory cassette

A published NSCLC-focused program coordinated several regulatory layers. Reported predictions included approximately 9× higher H3K27ac for the enhancer and 7.1× higher miRNA-mediated repression in healthy lung than A549 for the off-switch.

Source: Merchant et al., 2026 preprint, Figure 5 and Results §2.5. Not experimentally validated.

Interpretation: computational scores prioritize candidates and reduce search space; they do not guarantee biological function. Experimental validation remains essential.

Engagement models

Start with feasibility, then scale the design campaign.

Scopes below are intentionally modular and can be adapted to a single sequence element or a coordinated regulatory system.

Feasibility sprint

Determine whether the objective is computable with available models and define a credible campaign architecture.

  • Objective and data review
  • Model and constraint selection
  • Small pilot run
  • Go/no-go recommendation

Integrated regulatory program

Coordinate multiple sequence elements and regulatory layers around a shared functional objective.

  • Enhancer/promoter/intron/UTR design
  • Stage-wise handoff and scoring
  • System-level candidate selection
  • Methods and reproducibility package
FAQ

What clients should know before starting.

What information is needed for an initial review?

A target function, the sequence region that may change, fixed flanking context, target and off-target biological contexts, preferred assay, sequence length limits, and any synthesis or IP constraints.

Does the service include wet-lab validation?

This landing page is structured around computational design and analysis. Wet-lab work can be scoped through a qualified partner, but computational predictions should never be presented as experimentally confirmed results.

Can existing sequences be optimized rather than designed de novo?

Yes. Local mutation and MCMC-style refinement are often appropriate when preserving most of an existing construct is important. De novo or autoregressive generation is more suitable when broader novelty is acceptable.

How are model errors and overfitting managed?

By separating optimization models from hold-out evaluation where possible, testing multiple sequence contexts, examining each constraint independently, retaining sequence diversity, and flagging cases in which predictors disagree.

Is this service affiliated with the Proto developers?

No. This is an independent service concept built around publicly available Proto workflows. Any commercial page should retain a clear non-affiliation statement unless a formal relationship exists.

Online Inquiry

Submit your project details below, and our team will respond within 24 hours.

x
Need help getting the data you need?

Talk to our technical team about your project!

I Want To Talk
logo
Give us a free call

Send us an email

Copyright © CD ComputaBio. All Rights Reserved.
Top